For more than two decades, Peter Malamis has strategically guided the growth and development of service firms supporting biopharma clinical research and commercialization. Most recently, as Vice President and General Manager at the MAPI Group, he helped lead the acquisition and integration of Registrat, Inc. in a transaction that created the largest global CRO exclusively devoted to post-marketing research.
Previous to MAPI, as President of US Operations for the CRO Premier Research, Mr. Malamis led that group to the highest growth rates and profitability it had ever achieved. Prior to Premier, he held executive positions at SCIREX (US-focused CRO acquired by Premier), Galt Associates (drug safety and software services), MEDTAP International (health economics and outcomes), PAREXEL International (global CRO), State & Federal Associates (market access services).
Mr. Malamis obtained his B.A. in Political Science at the University of Richmond and his M.B.A. in Marketing from George Washington University. He has served as a Board member and advisor to several early-stage biopharma services companies and is a regular lecturer at Drexel University’s LeBow College of Business MBA in Pharmaceutical Management program as well as at industry conferences.